Health Technology Assessment (HTA) may sound like something that you don't want to know more about. But you should, because it's one of the last crucial steps on the way to getting new medical treatments to patients. HTA is the scientific process that informs decision and policy making at a country level - should a new treatment be reimbursed and if so for whom? A lot of different evidence, methods, disciplines, and perspectives must converge during HTA, and statisticians working in this area are truly the swiss army knives of medical statisticians. You need to juggle classical statistics, Bayesian statistics, epidemiological methods and health economic modeling, right at the edge before a new medicine reaches the pharmacy shelves. It's both rewarding and fun, and in this talk I'll explain why.